Information Provided By: 
Fly News Breaks for May 20, 2015
ICPT
May 20, 2015 | 07:05 EDT
Baird said the update from Intercept on its P3 trial design was in-line with expectations and the firm sees no reason for the stock to be down on what appears to be a clear and reasonable approval pathway. Baird reiterated its Outperform rating and $344 price target on Intercept shares.
News For ICPT From the Last 2 Days
There are no results for your query ICPT
